000 | 01887 a2200529 4500 | ||
---|---|---|---|
005 | 20250518080153.0 | ||
264 | 0 | _c20210503 | |
008 | 202105s 0 0 eng d | ||
022 | _a1522-9653 | ||
024 | 7 |
_a10.1016/j.joca.2019.12.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatt, F E | |
245 | 0 | 0 |
_aThe molecular profile of synovial fluid changes upon joint distraction and is associated with clinical response in knee osteoarthritis. _h[electronic resource] |
260 |
_bOsteoarthritis and cartilage _c03 2020 |
||
300 |
_a324-333 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActivins _xmetabolism |
650 | 0 | 4 |
_aCell Adhesion Molecules _xmetabolism |
650 | 0 | 4 |
_aChemokine CCL2 _xmetabolism |
650 | 0 | 4 | _aExternal Fixators |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 |
_aInterleukin-8 _xmetabolism |
650 | 0 | 4 |
_aLatent TGF-beta Binding Proteins _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrthopedic Procedures _xmethods |
650 | 0 | 4 |
_aOsteoarthritis, Knee _xmetabolism |
650 | 0 | 4 |
_aSynovial Fluid _xmetabolism |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xmetabolism |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHamid, B | |
700 | 1 | _aGarriga, C | |
700 | 1 | _aJudge, A | |
700 | 1 | _aHrusecka, R | |
700 | 1 | _aCusters, R J H | |
700 | 1 | _aJansen, M P | |
700 | 1 | _aLafeber, F P | |
700 | 1 | _aMastbergen, S C | |
700 | 1 | _aVincent, T L | |
773 | 0 |
_tOsteoarthritis and cartilage _gvol. 28 _gno. 3 _gp. 324-333 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.joca.2019.12.005 _zAvailable from publisher's website |
999 |
_c30486414 _d30486414 |